Clearmind Medicine Inc. Common Shares
Follow $CMND
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $CMND by emailVeridion Score
BETALOW CONF · 4 of 6 factors measuredHighest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is CMND moving today?
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
CMND overview
Related filings and maps
Congress activity in CMND
No receipt-qualified filings found.
CMND contract awards, year to date.
Public federal awards linked to this ticker.
CMND lobbying filings, year to date.
Registered lobbying filings matched to Clearmind Medicine Inc. Common Shares.
MCLARTY INBOUND LLC
MCLARTY INBOUND LLC
MCLARTY INBOUND LLC